Dexrazoxane hydrochloride is a cardioprotective agent. It was discovered by Kurt
Hellmann in 1972. Dexrazoxane is a sterile, pyrogen-free lyophilizate intended ...
Nov 15, 2015 ... Dexrazoxane Injection: learn about side effects, dosage, special precautions, and
more on MedlinePlus.
[PubChem] The Food and Drug Administration has designated dexrazoxane as
an orphan drug for use in the prevention or reduction in the incidence and ...
Zinecard is the trade name for dexrazoxane. In some cases, health care
professionals may use the trade name zinecard when referring to the generic
drug name ...
ZINECARD® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate
intended for intravenous administration. It is a cardioprotective agent for use in ...
Jul 2, 2013 ... On September 6, 2007, the FDA approved dexrazoxane hydrochloride for
injection (Totect™ made by TopoTarget USA, Inc.), equivalent to 500 ...
Dexrazoxane official prescribing information for healthcare professionals.
Includes: indications, dosage, adverse reactions, pharmacology and more.
Jan 6, 2017 ... Easy to read patient leaflet for dexrazoxane. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Medscape - Indication-specific dosing for Totect, Zinecard (dexrazoxane),
frequency-based adverse effects, comprehensive interactions, contraindications,
Sep 15, 2014 ... For more than half a century, the different properties of dexrazoxane have
captured the attention of scientists and clinicians. Presently ...